14 July 2020
Russia’s Vektor State Research Center for Virology and Biotechnologies has successfully completed pre-clinical trials of an anti-coronavirus vaccine, Anna Popova, chief of the Russian sanitary watchdog, said on July 10.
Colleagues have finished pre-clinical trials. They were successful. Actually, we have practically all the grounds to be sure that things will go as we promised, i.e. We plan to begin clinical trials on july 15,” she said in an interview with the vesti news program on the rossiya-1 television channel.
Russian Deputy Prime Minister Tatiana Golikova said earlier that works on the development of an anti-coronavirus vaccine proceeded as scheduled.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024
Microbial burden assessment of solid pharmaceutical products
22 April 2024
Seasonal variation of microbial contamination in pharmaceutical cleanrooms
22 April 2024